BURCON NUTRASCIENCE CORP (BRCN) Stock Price, Forecast & Analysis
USA - NASDAQ:BRCN - CA1208311029 - Common Stock
BRCN Key Statistics, Chart & Performance
The current stock price of BRCN is 0.44 USD. In the past month the price decreased by -36.23%. In the past year, price decreased by -80.87%.
BRCN Latest News, Press Relases and Analysis
BRCN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SHW | SHERWIN-WILLIAMS CO/THE | 30.08 | 84.81B | ||
| ECL | ECOLAB INC | 35.23 | 72.64B | ||
| PPG | PPG INDUSTRIES INC | 12.53 | 21.72B | ||
| DD | DUPONT DE NEMOURS INC | 9.11 | 16.67B | ||
| IFF | INTL FLAVORS & FRAGRANCES | 14.19 | 15.89B | ||
| RPM | RPM INTERNATIONAL INC | 20.12 | 13.78B | ||
| ALB | ALBEMARLE CORP | N/A | 11.44B | ||
| NEU | NEWMARKET CORP | 16.42 | 7.31B | ||
| EMN | EASTMAN CHEMICAL CO | 9.39 | 7.03B | ||
| ESI | ELEMENT SOLUTIONS INC | 18.82 | 6.68B | ||
| AXTA | AXALTA COATING SYSTEMS LTD | 11.6 | 6.28B | ||
| BCPC | BALCHEM CORP | 30.7 | 4.95B |
Related stock screener links
About BRCN
Company Profile
Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries in Canada. The company is headquartered in Vancouver, British Columbia and currently employs 19 full-time employees. The firm is engaged in development of plant protein extraction and purification technology in the field of functional, renewable plant proteins. The firm has a portfolio of composition, application and process patents covering plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds. The firm has developed pea proteins that it has branded Peazazz and Peazac, and over three canola protein products, Puratein, Supertein and Nutratein. The firm also includes CLARISOY, which is a soy protein. The Company’s subsidiaries include Burcon NutraScience (MB) Corp. and Burcon NutraScience Holdings Corp.
Company Info
BURCON NUTRASCIENCE CORP
1946 Broadway W
Vancouver BRITISH COLUMBIA CA
CEO: Johann Franz Tergesen
Employees: 19
Phone: 16047330896.0
BURCON NUTRASCIENCE CORP / BRCN FAQ
What does BRCN do?
Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries in Canada. The company is headquartered in Vancouver, British Columbia and currently employs 19 full-time employees. The firm is engaged in development of plant protein extraction and purification technology in the field of functional, renewable plant proteins. The firm has a portfolio of composition, application and process patents covering plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds. The firm has developed pea proteins that it has branded Peazazz and Peazac, and over three canola protein products, Puratein, Supertein and Nutratein. The firm also includes CLARISOY, which is a soy protein. The Company’s subsidiaries include Burcon NutraScience (MB) Corp. and Burcon NutraScience Holdings Corp.
What is the stock price of BURCON NUTRASCIENCE CORP today?
The current stock price of BRCN is 0.44 USD. The price decreased by -4.78% in the last trading session.
What is the dividend status of BURCON NUTRASCIENCE CORP?
BRCN does not pay a dividend.
What is the ChartMill technical and fundamental rating of BRCN stock?
BRCN has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the valuation of BURCON NUTRASCIENCE CORP (BRCN) based on its PE ratio?
BURCON NUTRASCIENCE CORP (BRCN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).
What is the expected growth for BRCN stock?
The Revenue of BURCON NUTRASCIENCE CORP (BRCN) is expected to grow by 489.89% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
BRCN Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BRCN. When comparing the yearly performance of all stocks, BRCN is a bad performer in the overall market: 93.25% of all stocks are doing better.
BRCN Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to BRCN. While BRCN has a great health rating, there are worries on its profitability.
BRCN Financial Highlights
Over the last trailing twelve months BRCN reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -416.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -4537.09% | ||
| ROA | -43.62% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
BRCN Forecast & Estimates
11 analysts have analysed BRCN and the average price target is 1.67 USD. This implies a price increase of 279.09% is expected in the next year compared to the current price of 0.44.
For the next year, analysts expect an EPS growth of -26.67% and a revenue growth 489.89% for BRCN